EP300 and neoplasm: Collectively, the presented study reports the identification of a novel epigenetic signature for tracing ccRCC tumor tissues based on low-p300/H3AcK18 vs high-H3AcK14 ratio in global histone H3 acetylation, distinctive of low-grade G1 tumors, and prognosticators for tumor aggressiveness.